Depreciation in USD of Cytek Biosciences, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cytek Biosciences, Inc. quarterly/annual Depreciation history and change rate from Q2 2020 to Q3 2025.
  • Cytek Biosciences, Inc. Depreciation for the quarter ending 30 Sep 2025 was $1,000,000.000, a 11.1% increase year-over-year.
  • Cytek Biosciences, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $3,800,000.000, a 11.8% increase year-over-year.
  • Cytek Biosciences, Inc. annual Depreciation for 2024 was $3,500,000.000, a 25% increase from 2023.
  • Cytek Biosciences, Inc. annual Depreciation for 2023 was $2,800,000.000, a 64.7% increase from 2022.
  • Cytek Biosciences, Inc. annual Depreciation for 2022 was $1,700,000.000, a 88.9% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Cytek Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3,800,000 $1,000,000 +$100,000 +11.1% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $3,700,000 $1,000,000 +$100,000 +11.1% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $3,600,000 $900,000 +$100,000 +12.5% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $3,500,000 $900,000 +$100,000 +12.5% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $3,400,000 $900,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $3,400,000 $900,000 +$300,000 +50% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $3,100,000 $800,000 +$300,000 +60% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $2,800,000 $800,000 +$200,000 +33.3% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $2,600,000 $900,000 +$500,000 +1.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $2,100,000 $600,000 +$200,000 +50% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $1,900,000 $500,000 +$200,000 +66.7% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $1,700,000 $600,000 +$258,000 +75.4% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $1,442,000 $400,000 +$208,000 +1.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $1,234,000 $400,000 +$201,000 +1% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $1,033,000 $300,000 +$133,000 +79.6% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $900,000 $342,000 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2024
Q3 2021 $192,000 +$29,000 +17.8% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $199,000 +$46,000 +30.1% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $167,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 $163,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $153,000 01 Apr 2020 30 Jun 2020 10-Q 03 Sep 2021

Cytek Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3,500,000 +$700,000 +25% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $2,800,000 +$1,100,000 +64.7% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $1,700,000 +$800,000 +88.9% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $900,000 +$400,000 +80% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024
2020 $500,000 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.